These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 436334)

  • 21. [The immune response in Hodgkin's disease].
    Schneider M; Schwarzenberg L; Amiel JL; Hayat M; Mascaro G; Otmezguine Y; Mathé G
    Presse Med (1893); 1970 Oct; 78(41):1769-74. PubMed ID: 4097017
    [No Abstract]   [Full Text] [Related]  

  • 22. [Cellular immunity in patients with Hodgkin's disease: modification induced by incubating lymphocytes with fetal calf serum and Hodgkin's serum].
    Rambotti P; Velardi A; Spinozzi F; Falini B; Martelli MF
    Boll Ist Sieroter Milan; 1979 Mar; 58(1):90-9. PubMed ID: 552840
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Deficiency of lymphocyte antigen recognition in Hodgkin's disease.
    Gaines JD; Gilmer MA; Remington JS
    Natl Cancer Inst Monogr; 1973 May; 36():117-21. PubMed ID: 4744572
    [No Abstract]   [Full Text] [Related]  

  • 24. Lymphocyte transformation and production of a human mononuclear leucocyte chemotactic factor in patients with Hodgkin's disease.
    Rühl H; Vogt W; Bochert G; Schmidt S; Schaoua H; Moelle R
    Clin Exp Immunol; 1974 Jul; 17(3):407-15. PubMed ID: 4468860
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Hypothesis of occupational etiology of Hodgkin's and non-Hodgkin's lymphoma: a case-control study].
    Binaschi S; Santoro G; Introini U
    G Ital Med Lav; 1985; 7(5-6):181-6. PubMed ID: 3842815
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro evidence of normal lymphocyte function in some patients with Hodgkin's disease and negative delayed cutaneous hypersensitivity.
    Churchill WH; Rocklin RR; Moloney WC; David JR
    Natl Cancer Inst Monogr; 1973 May; 36():99-106. PubMed ID: 4583000
    [No Abstract]   [Full Text] [Related]  

  • 27. Quantitation of immunocompetence in Hodgkin's disease.
    Faguet GB
    J Clin Invest; 1975 Oct; 56(4):951-7. PubMed ID: 1159096
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The effect of phytohemagglutinin on lymphocytes in Hodgkin's disease].
    Eggerth G; Kühböck J; Pokorny D
    Wien Z Inn Med; 1969; 50(7):314-9. PubMed ID: 5380683
    [No Abstract]   [Full Text] [Related]  

  • 29. Impaired lymphocyte transformation in Hodgkin's disease. Evidence for depletion of circulating t-lymphocytes.
    Matchett KM; Huang AT; Kremer WB
    J Clin Invest; 1973 Aug; 52(8):1908-17. PubMed ID: 4541673
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum zinc levels, lymphocyte counts and functions in pediatric Hodgkin's disease.
    Babacan E; Cavdar AO; Arcasoy A
    Boll Ist Sieroter Milan; 1977 Jul; 56(3):228-34. PubMed ID: 901636
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Preparation of soluble extracts with mitogenic activity on human lymphocytes from 3 varieties of common beans (Phaseolus vulgaris). Determination of their reliability for clinical use].
    Said-Fernández S; Navarro-Marmolejo L; Montes de Oca R; Sánchez-Anzaldo FJ; Leal-Garza C; González-Garza MT
    Arch Invest Med (Mex); 1987; 18(3):193-8. PubMed ID: 3426353
    [No Abstract]   [Full Text] [Related]  

  • 32. A micro-method for PHA-induced stimulation of human lymphocytes. II. communication: effect of splenectomy on the inhibitory activity of serum in patients with Hodgkin's disease.
    Pappas A; Pees H; Girmann G
    Z Immunitatsforsch Immunobiol; 1977 Apr; 153(1):1-10. PubMed ID: 868205
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Assays in delayed hypersensitivity in the course of Hodgkin's disease].
    Bernadou A; Zittoun R; Blanc CM; Smadja R; Bousser J
    Ann Med Interne (Paris); 1970 Mar; 121(3):301-11. PubMed ID: 5507504
    [No Abstract]   [Full Text] [Related]  

  • 34. Phaseolus vulgaris L. var. HUR 15--a potential indigenous source for commercial PHA preparation.
    Sengupta S; Sengupta LK
    Indian J Exp Biol; 1992 Dec; 30(12):1203-5. PubMed ID: 1294485
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lymphocyte function in Hodgkin's Disease.
    Benninghoff DL; Girardet R
    Lymphology; 1976 Mar; 9(1):39-42. PubMed ID: 1263573
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neoplastic cells obtained from Hodgkin's disease function as accessory cells for mitogen-induced human T cell proliferative responses.
    Fisher RI; Bates SE; Bostick-Bruton F; Tuteja N; Diehl V
    J Immunol; 1984 May; 132(5):2672-7. PubMed ID: 6609204
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immune status of untreated patients with Hodgkin's disease and prognosis.
    Björkholm M; Wedelin C; Holm G; Ogenstad S; Johansson B; Mellstedt H
    Cancer Treat Rep; 1982 Apr; 66(4):701-9. PubMed ID: 7074640
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Monocyte PGE2 secretion in Hodgkin's disease and its relation to decreased cellular immunity.
    Passwell J; Levanon M; Davidsohn J; Ramot B
    Clin Exp Immunol; 1983 Jan; 51(1):61-8. PubMed ID: 6572580
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Considerations on the action of phytohemagglutinins, tuberculin antigens and Kveim's antigen on lymphocyte cultures of patients with sarcoidosis and Hodgkin's disease].
    Ricci M; Lenzini L; Passaleva A; Ricca M
    Folia Allergol (Roma); 1966; 13(1):11-4. PubMed ID: 5929596
    [No Abstract]   [Full Text] [Related]  

  • 40. [Immunologic defects in Hodgkin's disease].
    De Sanctis C; Fabris C; Ciriotti G; Ponzone A
    Minerva Pediatr; 1969 Sep; 21(38):1743-52. PubMed ID: 5362709
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.